Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 123 entries
View as:

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Phase: N/A Priority: Normal
NCT ID: NCT05639556 Org: User:
Start: 04/20/23 End: 12/31/28 Due: 12/31/29

The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00147342 Org: User:
Start: 05/31/05 End: 12/31/05 Due: 12/31/06

Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia

Phase: N/A Priority: Normal
NCT ID: NCT00587171 Org: User:
Start: 04/30/08 End: 10/31/09 Due: 10/31/10

Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia

Phase: N/A Priority: Normal
NCT ID: NCT00789672 Org: User:
Start: 01/31/09 End: 12/31/09 Due: 12/31/10

Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia

Phase: N/A Priority: Normal
NCT ID: NCT00094744 Org: User:
Start: 05/31/01 End: 09/30/03 Due: 09/30/04

Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old

Phase: N/A Priority: Normal
NCT ID: NCT00780741 Org: User:
Start: 10/31/08 End: 01/31/12 Due: 01/31/13

Strategies to Enhance New CGM Use in Early Childhood (SENCE)

Phase: N/A Priority: Normal
NCT ID: NCT02912728 Org: User:
Start: 01/30/17 End: 06/30/19 Due: 06/30/20

Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System

Phase: N/A Priority: Normal
NCT ID: NCT01271023 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children

Phase: N/A Priority: Normal
NCT ID: NCT00091923 Org: User:
Start: 02/29/04 End: 12/31/05 Due: 12/31/06

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Phase: N/A Priority: Normal
NCT ID: NCT00607139 Org: User:
Start: 12/31/06 End: 04/30/07 Due: 04/30/08

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Phase: N/A Priority: Normal
NCT ID: NCT05589714 Org: User:
Start: 05/11/23 End: 12/15/30 Due: 12/15/31

Surgical Idiopathic Intracranial Hypertension Treatment Trial

Phase: N/A Priority: Normal
NCT ID: NCT03501966 Org: User:
Start: 02/06/19 End: 08/28/19 Due: 08/28/20

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00891995 Org: User:
Start: 09/30/10 End: 10/31/13 Due: 10/31/14

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Phase: N/A Priority: Normal
NCT ID: NCT01323348 Org: User:
Start: 10/31/11 End: 01/31/15 Due: 01/31/16

Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00406133 Org: User:
Start: 12/31/06 End: 02/28/09 Due: 02/28/10

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT01489189 Org: User:
Start: 03/31/12 End: 02/05/18 Due: 02/05/19

Pilot Study of the Navigator Continuous Glucose Monitor

Phase: N/A Priority: Normal
NCT ID: NCT00166673 Org: User:
Start: 08/31/05 End: 08/31/07 Due: 08/31/08

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT06957028 Org: User:
Start: 05/01/25 End: 11/01/27 Due: 11/01/28

Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity

Phase: N/A Priority: Normal
NCT ID: NCT02390531 Org: User:
Start: 04/28/15 End: 05/11/21 Due: 05/11/22

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Phase: N/A Priority: Normal
NCT ID: NCT05904028 Org: User:
Start: 11/09/23 End: 07/30/27 Due: 07/30/28

Trial Comparing Daily Atropine Versus Weekend Atropine

Phase: N/A Priority: Normal
NCT ID: NCT00094614 Org: User:
Start: 06/30/02 End: 04/30/03 Due: 04/30/04

Insulin Clamp Ancillary Study for Assessment of Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT02045290 Org: User:
Start: 01/31/14 End: 02/15/16 Due: 02/15/17

An Outpatient Pump Shutoff Pilot Feasibility and Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT01736930 Org: User:
Start: 01/31/12 End: 06/30/12 Due: 06/30/13

Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT01591681 Org: User:
Start: 11/30/12 End: 07/31/13 Due: 07/31/14

Convergence Insufficiency Treatment Study (CITS)

Phase: N/A Priority: Normal
NCT ID: NCT01515943 Org: User:
Start: 06/30/12 End: 01/31/15 Due: 01/31/16